MarkS. Gold

1.5k total citations · 1 hit paper
7 papers, 604 citations indexed

About

MarkS. Gold is a scholar working on Cellular and Molecular Neuroscience, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, MarkS. Gold has authored 7 papers receiving a total of 604 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Cellular and Molecular Neuroscience, 2 papers in Epidemiology and 2 papers in Public Health, Environmental and Occupational Health. Recurrent topics in MarkS. Gold's work include Substance Abuse Treatment and Outcomes (2 papers), Opioid Use Disorder Treatment (2 papers) and Alcohol Consumption and Health Effects (1 paper). MarkS. Gold is often cited by papers focused on Substance Abuse Treatment and Outcomes (2 papers), Opioid Use Disorder Treatment (2 papers) and Alcohol Consumption and Health Effects (1 paper). MarkS. Gold collaborates with scholars based in United States, Israel and United Kingdom. MarkS. Gold's co-authors include H D Kleber, D. Eugene Redmond, A.L.C. Pottash, Arnold M. Washton, Kimberly Frost-Pineda, Candace Hodgkins, James A. Cocores, Louis B. Schlesinger, Kenneth Blum and Marcelo Febo and has published in prestigious journals such as The Lancet, Psychosomatics and Journal of Addictive Diseases.

In The Last Decade

MarkS. Gold

7 papers receiving 536 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

CLONIDINE BLOCKS ACUTE OPIATE-WITHDRAWAL SYMPTOMS

1978 538 citations MarkS. Gold, D. Eugene Redmond et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
MarkS. Gold United States	6	323	212	104	79	71	7	604
H D Kleber	7	393 1.2×	255 1.2×	138 1.3×	90 1.1×	66 0.9×	8	697
Anne Roussin France	16	219 0.7×	167 0.8×	58 0.6×	146 1.8×	58 0.8×	42	696
X Lamas Spain	10	404 1.3×	145 0.7×	51 0.5×	60 0.8×	23 0.3×	13	625
Phillip Saccone United States	11	223 0.7×	86 0.4×	108 1.0×	125 1.6×	39 0.5×	18	452
Lisa H. Brauer United States	14	291 0.9×	212 1.0×	242 2.3×	45 0.6×	97 1.4×	19	714
A.L.C. Pottash United States	20	336 1.0×	198 0.9×	127 1.2×	102 1.3×	258 3.6×	53	1.3k
Joseph R. Holtman United States	19	284 0.9×	196 0.9×	339 3.3×	129 1.6×	26 0.4×	38	1.0k
Thomas R. Kosten United States	15	482 1.5×	202 1.0×	60 0.6×	220 2.8×	112 1.6×	16	910
Caroline A. Arout United States	14	196 0.6×	87 0.4×	225 2.2×	63 0.8×	106 1.5×	25	555
Jeffrey Van Kirk United States	10	298 0.9×	111 0.5×	86 0.8×	116 1.5×	101 1.4×	11	758

Countries citing papers authored by MarkS. Gold

Since Specialization

Citations

This map shows the geographic impact of MarkS. Gold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by MarkS. Gold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites MarkS. Gold more than expected).

Fields of papers citing papers by MarkS. Gold

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by MarkS. Gold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by MarkS. Gold. The network helps show where MarkS. Gold may publish in the future.

Co-authorship network of co-authors of MarkS. Gold

This figure shows the co-authorship network connecting the top 25 collaborators of MarkS. Gold. A scholar is included among the top collaborators of MarkS. Gold based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with MarkS. Gold. MarkS. Gold is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Blum, Kenneth, Abdalla Bowirrat, MarkS. Gold, et al.. (2023). How to Combat the Global Opioid Crisis.. PubMed. 5(4). 5 indexed citations

2.

Blum, Kenneth, Thomas McLaughlin, Edward J. Modestino, et al.. (2021). Epigenetic Repair of Terrifying Lucid Dreams by Enhanced Brain Reward Functional Connectivity and Induction of Dopaminergic Homeo - static Signaling. PubMed. 10(3). 170–180. 6 indexed citations

3.

Hodgkins, Candace, Kimberly Frost-Pineda, & MarkS. Gold. (2007). Weight Gain During Substance Abuse Treatment. Journal of Addictive Diseases. 26(sup1). 41–50. 12 indexed citations

4.

Cocores, James A., Louis B. Schlesinger, & MarkS. Gold. (1987). A Review of the EEG Literature on Ganser's Syndrome. The International Journal of Psychiatry in Medicine. 16(1). 59–65. 5 indexed citations

5.

Gold, MarkS., et al.. (1987). Diagnosis of Substance Abuse in an Adolescent Psychiatric Population. The International Journal of Psychiatry in Medicine. 16(2). 137–143. 21 indexed citations

6.

Washton, Arnold M., MarkS. Gold, & A.L.C. Pottash. (1984). Survey of 500 callers to a national cocaine helpline. Psychosomatics. 25(10). 771–775. 17 indexed citations

7.

Gold, MarkS., D. Eugene Redmond, & H D Kleber. (1978). CLONIDINE BLOCKS ACUTE OPIATE-WITHDRAWAL SYMPTOMS. The Lancet. 312(8090). 599–602. 538 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact